Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer

Prostate cancer is the third most common cause of male cancer death in developed countries, and one of the most comprehensively characterized human cancers. Roughly 60% of prostate cancers harbor gene fusions that juxtapose ETS-family transcription factors with androgen regulated promoters. A second...

Descripción completa

Detalles Bibliográficos
Autores principales: Annala, Matti, Kivinummi, Kati, Tuominen, Joonas, Karakurt, Serdar, Granberg, Kirsi, Latonen, Leena, Ylipää, Antti, Sjöblom, Liisa, Ruusuvuori, Pekka, Saramäki, Outi, Kaukoniemi, Kirsi M., Yli-Harja, Olli, Vessella, Robert L., Tammela, Teuvo L.J, Zhang, Wei, Visakorpi, Tapio, Nykter, Matti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467434/
https://www.ncbi.nlm.nih.gov/pubmed/25749039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467434/
https://www.ncbi.nlm.nih.gov/pubmed/25749039

Ejemplares similares